Joint Research and Development, LLC (JRAD), a recognized leader in the Chemical and Biological Defense (CBD) community, has been awarded…
Joint Research and Development LLC (JRAD) announces award for the U.S. Air Force IAC MAC Contract
On Monday, September 30th, the Department of Defense announced JRAD as one of the awardees for the U.S. Air Force…
Joint Research and Development Acquires Global Systems Technologies
GST is a leading provider of test and evaluation services, model-based systems engineering, logistics, and research and development…
Sayres Defense Acquires Joint Research and Development for GovCon Platform Business
With long legacies of outstanding performance in the GovCon national security market, JRAD and Sayres will now be working together…
Highlights
Dr. Svetlana “Lana” Hopkins, senior scientist and subject matter expert at JRAD, was recently awarded the Major General Harold J. “Harry” Greene Awards for Acquisition Writing for the publication “Technologically Advanced Response System to High Consequential Biological Threats.” Dr. Hopkins co-authored the article with Dr. Christopher G. Earnhart, Chief Technology Officer at the JPEO-CBRND’s JPL CBRND EB.
Their article successfully explained the tremendous impact that an infectious disease, and to a greater extent a biowarfare attack, can have on Warfighter operational availability and survivability. The article laid out the importance of the JPL CBRND EB’s mission and the value that the entire Chem Bio Defense Program brings to the nation’s Defense Department.
Dr. Shanmuga Sozhamannan and a team of experts were recently recognized for their contributions to the genetic sequencing community by the AOAC Official Methods Board. This team’s paper on standards guidance, titled, “Amplicon Sequencing Minimal Information (ASqMI): Quality and Reporting Guidelines for Actionable Calls in Biodefense Applications”, was the 2024 recipient of the AOAC Award in Recognition of Technical and Scientific Excellence.
The AOAC Official Methods Board commended the paper for its level of research, novelty, unique innovation, and broad impact to the community.